Mitotic accumulations of PML protein contribute to the re-establishment of PML nuclear bodies in G1

Journal of Cell Science

Volumn 119, Issue 6, 2006, Pages 1034-1042

  Dellaire, Graham ^a   Eskiw, Christopher H ^a   Dehghani, Hesam ^a,b   Ching, Reagan W ^a   Bazett Jones, David P ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

Author keywords

Electron spectroscopic imaging; Mitosis; Nuclear bodies; PML; Proteasome inhibition

Indexed keywords

DAXX PROTEIN; PROMYELOCYTIC LEUKEMIA PROTEIN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SP100; UNCLASSIFIED DRUG;

ANAPHASE; ARTICLE; BIOCHEMISTRY; CELL CYCLE G1 PHASE; CELL NUCLEUS INCLUSION BODY; CELL NUCLEUS MEMBRANE; CELL STRUCTURE; CHROMOSOME CONDENSATION; CHROMOSOME SEGREGATION; CONTROLLED STUDY; CYTOKINESIS; CYTOPLASM; DAUGHTER CELL; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; HUMAN; HUMAN CELL; MITOSIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

ANTIGENS, NUCLEAR; AUTOANTIGENS; CHROMATIN; G1 PHASE; HELA CELLS; HUMANS; INTRANUCLEAR INCLUSION BODIES; MITOSIS; NEOPLASM PROTEINS; NUCLEAR MATRIX; NUCLEAR PROTEINS; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 33645749156     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02817     Document Type: Article

References (40)

1. Boisvert, F. M., Hendzel, M. J. and Bazett-Jones, D. P. (2000). Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. J. Cell Biol. 148, 283-292.
2. Borden, K. L. (2002). Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies. Mol. Cell. Biol. 22, 5259-5269.
3. Burke, B. and Ellenberg, J. (2002). Remodelling the walls of the nucleus. Nat. Rev. Mol. Cell. Biol. 3, 487-497.
4. Chang, K. S., Fan, Y. H., Andreeff, M., Liu, J. and Mu, Z. M. (1995). The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85, 3646-3653.
5. Ching, R. W., Dellaire, G., Eskiw, C. H. and Bazett-Jones, D. P. (2005). PML bodies: a meeting place for genomic loci? J. Cell Sci. 118, 847-854.
6. de Bruyn Kops, A. and Knipe, D. M. (1994). Preexisting nuclear architecture defines the intranuclear location of herpesvirus DNA replication structures. J. Virol. 68, 3512-3526.
7. Dellaire, G. and Bazett-Jones, D. P. (2004). PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. BioEssays 26, 963-977.
8. Dellaire, G., Nisman, R. and Bazett-Jones, D. P. (2004). Correlative light and electron spectroscopic imaging of chromatin in situ. Methods Enzymol. 375, 456-478.
9. Dellaire, G., Ching, R. W., Dehghani, H., Ren, Y. and Bazett-Jones, D. P. (2006). The number of PML nuclear bodies increases in early S phase by a fission mechanism. J. Cell Sci. 119, 1026-1033.
10. Eskiw, C. H., Dellaire, G., Mymryk, J. S. and Bazett-Jones, D. P. (2003). Size, position and dynamic behavior of PML nuclear bodies following cell stress as a paradigm for supramolecular trafficking and assembly. J. Cell Sci. 116, 4455-4466.
11. Eskiw, C. H., Dellaire, G. and Bazett-Jones, D. P. (2004). Chromatin contributes to structural integrity of promyelocytic leukemia bodies through a SUMO-1-independent mechanism. J. Biol. Chem. 279, 9577-9585.
12. Everett, R. D. (2001). DNA viruses and viral proteins that interact with PML nuclear bodies. Oncogene 20, 7266-7273.
13. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R. and Orr, A. (1999). Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588.
14. Grobelny, J. V., Godwin, A. K. and Broccoli, D. (2000). ALT-associated PML bodies are present in viable cells and are enriched in cells in the G(2)/M phase of the cell cycle. J. Cell Sci. 113, 4577-4585.
15. Hartmann-Petersen, R., Seeger, M. and Gordon, C. (2003). Transferring substrates to the 26S proteasome. Trends Biochem. Sci. 28, 26-31.
16. Hendzel, M. J., Wei, Y., Mancini, M. A., Van Hooser, A., Ranalli, T., Brinkley, B. R., Bazett-Jones, D. P. and Allis, C. D. (1997). Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348-360.
17. Hernandez-Verdun, D., Roussel, P. and Gebrane-Younes, J. (2002). Emerging concepts of nucleolar assembly. J. Cell Sci. 115, 2265-2270.
18. Ishov, A. M., Vladimirova, O. V. and Maul, G. G. (2004). Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX. J. Cell Sci. 117, 3807-3820.
19. Kentsis, A., Dwyer, E. C., Perez, J. M., Sharma, M., Chen, A., Pan, Z. Q. and Borden, K. L. (2001). The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E. J. Mol. Biol. 312, 609-623.
20. Koken, M. H., Linares-Cruz, G., Quignon, F., Viron, A., Chelbi-Alix, M. K., Sobczak-Thepot, J., Juhlin, L., Degos, L., Calvo, F. and de The, H. (1995). The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 10, 1315-1324.
21. Lallemand-Breitenbach, V., Zhu, J., Puvion, F., Koken, M., Honore, N., Doubeikovsky, A., Duprez, E., Pandolfi, P. P., Puvion, E., Freemont, P. et al. (2001). Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As203-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 193, 1361-1371.
22. Leung, A. K. and Lamond, A. I. (2003). The dynamics of the nucleolus. Crit. Rev. Eukaryol. Gene Expr 13, 39-54.
23. Lin, H. K., Bergmann, S. and Pandolfi, P. P. (2004). Cytoplasmic PML function in TGF-beta signalling. Nature 431, 205-211.
24. Maul, G. G. (1998). Nuclear domain 10, the site of DNA virus transcription and replication. BioEssays 20, 660-667.
25. Prasanth, K. V., Sacco-Bubulya, P. A., Prasanth, S. G. and Spector, D. L. (2003). Sequential entry of components of the gene expression machinery into daughter nuclei. Mol. Biol. Cell 14, 1043-1057.
26. Regad, T. and Chelbi-Alix, M. K. (2001). Role and fate of PML. nuclear bodies in response to interferon and viral infections. Oncogene 20, 7274-7286.
27. Roussel, P., Andre, C., Masson, C., Geraud, G. and Hernandez-Verdun, D. (1993). Localization of the RNA polymerase I transcription factor hUBF during the cell cycle. J. Cell Sci. 104, 327-337.
28. Roussel, P., Andre, C., Comai, L. and Hernandez-Verdun, D. (1996). The rDNA transcription machinery is assembled during mitosis in active NORs and absent in inactive NORs. J. Cell Biol. 133, 235-246.
29. Salomoni, P. and Pandolfi, P. P. (2002). The role of PML in tumor suppression. Cell 108, 165-170.
30. Shiels, C., Islam, S. A., Vatcheva, R., Sasieni, P., Sternberg, M. J., Freemont, P. S. and Sheer, D. (2001). PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J. Cell Sci. 114, 3705-3716.
31. Sternsdorf, T., Jensen, K. and Will, H. (1997). Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PICI/SUMO-1. J. Cell Biol. 139, 1621-1634.
32. Stuurman, N., de Graaf, A., Floore, A., Josso, A., Humbel, B., de Jong, L. and van Driel, R. (1992). A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies. J. Cell Sci. 101, 773-784.
33. Sugata, N., Li, S., Earnshaw, W. C., Yen, T. J., Yoda, K., Masumoto, H., Munekata, E., Warburton, P. E. and Todokoro, K. (2000). Human CENP-H multimers colocalize with CENP-A and CENP-C at active centromere-kinetochore complexes. Hum. Mol. Genet. 9, 2919-2926.
34. Swedlow, J. R. and Hirano, T. (2003). The making of the mitotic chromosome: modern insights into classical questions. Mol. Cell 11, 557-569.
35. Terris, B., Baldin, V., Dubois, S., Degott, C., Flejou, J. F., Henin, D. and Dejean, A. (1995). PML nuclear bodies are general targets for inflammation and cell proliferation. Cancer Res. 55, 1590-1597.
36. Wang, J., Shiels, C., Sasieni, P., Wu, P. J., Islam, S. A., Freemont, P. S. and Sheer, D. (2004). Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J. Cell Biol. 164, 515-526.
37. Wiesmeijer, K., Molenaar, C., Bekeer, I. M., Tanke, H. J. and Dirks, R. W. (2002). Mobile foci of Sp100 do not contain PML: PML bodies are immobile but PML and Sp100 proteins are not. J. Struct. Biol. 140, 180-188.
38. Williams, J. M., Boyd, B., Nutikka, A., Lingwood, C. A., Barnett Foster, D. E., Milford, D. V. and Taylor, C. M. (1999). A comparison ofthe effects of verocytotoxin-1 on primary human renal cell cultures. Toxicol. Lett. 105, 47-57.
39. Yeager, T. R., Neumann, A. A., Englezou, A., Huschtscha, L. I., Noble, J. R. and Reddel, R. R. (1999). Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Cancer Res. 59, 4175-4179.
40. Zhong, S., Salomoni, P. and Pandolfi, P. P. (2000). The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2, E85-E90.